MIAMI--(BUSINESS WIRE)--HistoCyte Laboratories Ltd (Newcastle upon Tyne, UK) and Vitro Molecular Laboratories LLC (Miami, FL) have signed a distribution agreement for the promotion of HistoCyte Laboratories Products in the USA. Through Vitro Molecular Laboratories affiliate, Ancillary Pathways LLC, HistoCyte Laboratories Ltd will have immediate access to their network of laboratory contacts. This will advance HistoCyte Laboratories commercial expansion and dissemination of their cell line based control material for use in immunohistochemistry (IHC) and in situ hybridisation (ISH). These products are unique as they closely resemble tissue morphology, producing immediately recognisable quality at an affordable price.
“For a company with a novel product, success depends upon the right partnerships. In partnering with Dr Yaziji through Vitro and Ancillary Pathways, we marry his team’s expertise with their network in the US market”
Colin Tristram, co- founder with Dr Ian Milton, expressed the HistoCyte team’s excitement directly supplying one of the world’s largest and innovative life science and biomedical markets. “For a company with a novel product, success depends upon the right partnerships. In partnering with Dr Yaziji through Vitro and Ancillary Pathways, we marry his team’s expertise with their network in the US market”. Dr Hadi Yaziji shares his team’s excitement, “We are equally thrilled to be able to rely upon the superb quality of cell lines by partnering with HistoCyte Laboratories Ltd and its experts”.
About HistoCyte Laboratories Ltd
HistoCyte Laboratories mission is to provide standardised control material for IHC and ISH. Traditionally tissues are used but these are not standardised across laboratories and can be of limited availability. HistoCyte Laboratories also provide contract development and manufacturing services to the biotech field. HistoCyte Laboratories have already established a distributor network across Europe and sell directly into the UK and Ireland.
About Ancillary Pathways LLC
Ancillary Pathways provide services to address the diverse needs of pathology laboratories of all sizes and in all settings. Their experts work collaboratively with laboratories to provide the specific training and logistical support needed for enhancing IHC and FISH testing capabilities. Ancillary Pathways is supported by an extensive network of experienced pathologists and scientists with many decades of practical experience in profitable laboratories. Internationally recognized physicians, scientists and technologists make up Ancillary Pathways’ growing Advisory Board.
Colin Tristram
HistoCyte Laboratories Ltd
+44(0)1916031007
colin.tristram@histocyte.com
